Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis : analysis of pooled data from the randomized trials SOLO 1 and SOLO 2
-
Cork, Michael J. (University of Sheffield Medical School)
;
Eckert, Laurent (Sanofi) ;
Simpson, Eric L. (Oregon Health & Science University) ;
Armstrong, April W (Keck School of Medicine at USC. University of Southern California) ;
Barbarot, Sebastien (CHU Hôtel-Dieu) ;
Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Girolomoni, Giampiero (University of Verona) ;
de Bruin-Weller, Marjolein (University Medical Center Utrecht) ;
Wollenberg, Andreas (Klinikum der Universität München) ;
Kataoka, Yoko (Osaka Habikino Medical Center) ;
Remitz, Anita (Helsinki University Central Hospital) ;
Beissert, Stefan (Technische Universität Dresden) ;
Mastey, Vera (Regeneron Pharmaceuticals Inc.) ;
Ardeleanu, Marius (Regeneron Pharmaceuticals Inc.) ;
Chen, Zhen (Regeneron Pharmaceuticals Inc.) ;
Gadkari, Abhijit (Regeneron Pharmaceuticals Inc.) ;
Chao, Jingdong (Regeneron Pharmaceuticals Inc.) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
